Literature DB >> 24458097

Eye care availability and access among individuals with diabetes, diabetic retinopathy, or age-related macular degeneration.

Diane M Gibson1.   

Abstract

IMPORTANCE Understanding whether differences in the local availability of eye care professionals are related to differences in realized access to eye care is important for assessing whether and where public health efforts are needed to increase access to eye care professionals. OBJECTIVE To examine whether the county-level availability of ophthalmologists and optometrists is associated with measures of realized access to eye care for individuals with diabetes mellitus, diabetic retinopathy, or age-related macular degeneration (ARMD). DESIGN, SETTING, AND PARTICIPANTS We studied a cross-sectional sample of US adults 40 years and older (1098 individuals with diabetes, 345 with diabetic retinopathy, and 498 with ARMD) from the 2005-2008 National Health and Nutrition Examination Survey. MAIN OUTCOMES AND MEASURES Outcomes were whether diabetic individuals reported undergoing a dilated eye examination in the past year, whether individuals were unaware they had diabetic retinopathy, whether diabetic individuals had vision-threatening diabetic retinopathy, and whether individuals were unaware they had ARMD. RESULTS In logistic regression models that also included individual characteristics, individuals who lived in a county in the highest ophthalmologist availability quartile were less likely to be unaware they had diabetic retinopathy (predictive margin [PM], 66.1%; 90% CI, 48.8%-83.4%; vs PM, 84.1%; 90% CI, 78.7%-89.6%) and were less likely to have vision-threatening diabetic retinopathy (PM, 1.4%; 90% CI, 0.9%-1.9%; vs PM, 2.6%; 90% CI, 1.8%-3.4%) than individuals who lived in a county in the lower 3 ophthalmologist availability quartiles. Individuals who lived in a county in the lowest ophthalmologist availability quartile were more likely to be unaware they had ARMD (PM, 93.8%; 90% CI, 90.6%-97.0%; vs PM, 88.3%; 90% CI, 84.7%-91.9%) than individuals who lived a county in the higher 3 ophthalmologist availability quartiles. Optometrist availability quartiles were not significantly related to any of the outcomes. CONCLUSIONS AND RELEVANCE The results suggest that efforts to increase access to ophthalmologists to improve outcomes related to diabetic retinopathy or to increase awareness of ARMD should focus on improving access for diabetic individuals who live in counties in the lowest 3 quartiles of ophthalmologist availability and on individuals at risk of ARMD who live in counties in the lowest quartile of ophthalmologist availability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24458097     DOI: 10.1001/jamaophthalmol.2013.7682

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  11 in total

1.  Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine.

Authors:  Cynthia Owsley; Gerald McGwin; David J Lee; Byron L Lam; David S Friedman; Emily W Gower; Julia A Haller; Lisa A Hark; Jinan Saaddine
Journal:  JAMA Ophthalmol       Date:  2015-02       Impact factor: 7.389

Review 2.  Clinical and Psychosocial Factors Influencing Retinal Screening Uptake Among Young Adults with Type 2 Diabetes.

Authors:  A J Lake; G Rees; J Speight
Journal:  Curr Diab Rep       Date:  2018-05-24       Impact factor: 4.810

3.  Association Between Geographic Distribution of Eye Care Clinicians and Visual Impairment in California.

Authors:  Karissa M Wang; Victoria L Tseng; Xiongfei Liu; Deyu Pan; Fei Yu; Richard Baker; Bartly J Mondino; Anne L Coleman
Journal:  JAMA Ophthalmol       Date:  2022-06-01       Impact factor: 8.253

4.  Comparison of automated and expert human grading of diabetic retinopathy using smartphone-based retinal photography.

Authors:  Tyson N Kim; Michael T Aaberg; Patrick Li; Jose R Davila; Malavika Bhaskaranand; Sandeep Bhat; Chaithanya Ramachandra; Kaushal Solanki; Frankie Myers; Clay Reber; Rohan Jalalizadeh; Todd P Margolis; Daniel Fletcher; Yannis M Paulus
Journal:  Eye (Lond)       Date:  2020-04-27       Impact factor: 3.775

5.  Using Public Datasets to Identify Priority Areas for Ocular Telehealth.

Authors:  Christopher J Brady; Samantha D'Amico; Natasha Withers; Brian Y Kim
Journal:  Telemed J E Health       Date:  2021-02-18       Impact factor: 3.536

6.  Impact of car transport availability and drive time on eye examination uptake among adults aged ≥60 years: a record linkage study.

Authors:  David M Wright; Dermot O'Reilly; Augusto Azuara-Blanco; Ruth E Hogg
Journal:  Br J Ophthalmol       Date:  2018-07-03       Impact factor: 4.638

7.  Quality indicators in type 2 diabetes patient care: analysis per care-complexity level.

Authors:  Josiane Schneiders; Gabriela H Telo; Leonardo Grabinski Bottino; Bruna Pasinato; Jeruza Lavanholi Neyeloff; Beatriz D Schaan
Journal:  Diabetol Metab Syndr       Date:  2019-05-02       Impact factor: 3.320

8.  Disparities in Receipt of Eye Exams Among Medicare Part B Fee-for-Service Beneficiaries with Diabetes - United States, 2017.

Authors:  Elizabeth A Lundeen; John Wittenborn; Stephen R Benoit; Jinan Saaddine
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-15       Impact factor: 17.586

Review 9.  Prevalence, Incidence and Ecological Determinants of Diabetic Retinopathy in Iran: Systematic Review and Meta-analysis.

Authors:  Golnoush Sadat Mahmoudi Nezhad; Reza Razeghinejad; Mohsen Janghorbani; Alireza Mohamadian; Mohammad Hassan Jalalpour; Somaye Bazdar; Alireza Salehi; Hossein Molavi Vardanjani
Journal:  J Ophthalmic Vis Res       Date:  2019-07-18

10.  Nonmydriatic Photographic Screening for Diabetic Retinopathy in Pregnant Patients with Pre-Existing Diabetes in a Safety Net Population: 1 Year Results from the Diabetic Retinopathy in Pregnant Patients Study.

Authors:  Malini Veerappan Pasricha; Jodi So; David Myung; Andrea Jelks; Carolyn K Pan
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.